- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/12 - 1,5-BenzodiazepinesHydrogenated 1,5-benzodiazepines
Patent holdings for IPC class C07D 243/12
Total number of patents in this class: 95
10-year publication summary
|
9
|
9
|
10
|
8
|
2
|
6
|
4
|
2
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nippon Chemiphar Co., Ltd. | 226 |
11 |
| Otsuka Pharmaceutical Co., Ltd. | 1502 |
6 |
| The Johns Hopkins University | 5882 |
5 |
| Purdue Research Foundation | 3916 |
5 |
| The Governors of the University of Alberta | 875 |
4 |
| Zeria Pharmaceutical Co., Ltd. | 101 |
4 |
| Lieber Institute, Inc. | 45 |
4 |
| F. Hoffmann-La Roche AG | 7837 |
3 |
| Constellation Pharmaceuticals, Inc. | 218 |
3 |
| Sanford Burnham Prebys Medical Discovery Institute | 308 |
3 |
| Hoffmann-La Roche Inc. | 3793 |
2 |
| Genentech, Inc. | 4104 |
2 |
| Bayer AG | 3501 |
2 |
| Bayer Pharma AG | 1014 |
2 |
| Commonwealth Scientific and Industrial Research Organisation | 1655 |
2 |
| Sanford-Burnham Medical Research Institute | 125 |
2 |
| Universita' degli Studi di Milano | 239 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3304 |
2 |
| Ventana Medical Systems, Inc. | 1070 |
2 |
| Fondazione Italiana Sclerosi Multipla—fism Onlus | 3 |
2 |
| Other owners | 27 |